超分子複合体を用いた間質圧の高い腫瘍への抗がん剤デリバリー

DOI Web Site Web Site PubMed 参考文献15件
  • 有馬 英俊
    熊本大学大学院生命科学研究部製剤設計学分野

書誌事項

タイトル別名
  • Delivery of Anticancer Drugs Using a Supramolecular Complex to Cancer Tissues Having High Interstitial Fluid Pressure
  • Symposium Review 超分子複合体を用いた間質圧の高い腫瘍への抗がん剤デリバリー
  • Symposium Review チョウブンシ フクゴウタイ オ モチイタ カンシツアツ ノ タカイ シュヨウ エ ノ コウガンザイ デリバリー

この論文をさがす

抄録

<p>Pancreatic cancer is the fourth-leading cause of death from cancer in Japan, after lung, colorectal, and stomach cancers and has the lowest survival among these tumors, because of not only no symptoms, no screening tool and no biomarkers but also high rates of recurrence and metastasis. In addition, pancreatic cancer has excessive stroma which serves as a severe biological barrier for anticancer drug delivery and successful treatment. Therefore, there are many challenges for drug delivery systems for the treatment of pancreatic cancer. Recently, we developed self-assembly PEGylation retaining activity (SPRA) technology, which comprises a reversible pegylated protein complex without loss of bioactivity. SPRA technology is based on a host-guest interaction between PEGylated β-cyclodextrin and adamantane-appended protein. In this review, first pancreatic cancer is introduced, second, principle drug delivery systems for the treatment of pancreatic cancer are described, and third the concept of SPRA technology as well as examples of SPRA proteins, especially focusing on the potential of SPRA-bromelain for treatment of pancreatic cancer, are introduced.</p>

収録刊行物

  • 薬学雑誌

    薬学雑誌 140 (5), 617-624, 2020-05-01

    公益社団法人 日本薬学会

参考文献 (15)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ